Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis

NCT04047576 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Retroperitoneal Fibrosis

Interventions

DRUG: Sirolimus
DRUG: Corticosteroid

Sponsor

Peking University International Hospital